FABP1 and metabolic dysfunction-associated steatotic liver disease: Oxidative stress and inflammation lead to disruption in L-FABP expression, which can lead to lipid accumulation and increased oxidative stress in hepatocytes, increasing the risk of insulin resistance and MASLD.